FindTrial
Sign In

Study to see effectiveness of alternative cheaper solution used in patients undergoing a calcium removing procedure(rotational atherectomy) during angioplasty.

To evaluate the efficacy of an alternative heparin based rota-flush solution in patients with severe coronary artery calcification undergoing rotational atherectomy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030597
Enrollment
50
Registered
2021-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I255- Ischemic cardiomyopathy Health Condition 2: I214- Non-ST elevation (NSTEMI) myocardial infarction Health Condition 3: I252- Old myocardial infarction Health Condition 4: I258- Other forms of chronic ischemic heart disease Health Condition 5: I21A- Other type of myocardial infarction Health Condition 6: I210- ST elevation (STEMI) myocardial infarction of anterior wall Health Condition 7: I211- ST elevation (STEMI) myocardial infarction of inferior wall Health Condition 8

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex aged >18 years 2. Patients underwent percutaneous coronary intervention (PCI) with rotational atherectomy performed by operating physicians at Department of cardiology, KGMU Lucknow.

Exclusion criteria

Exclusion criteria: 1. Patient with saphenous vein graft lesions 2. Patients with angiographic evidence of thrombus 3. Angiographic evidence of significant dissection at the treatment site 4. Patient with occlusions through which a guidewire could not be passed.

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of alternative heparin based rota-flush solution without vasodilator, as compared to rota-flush solution containing vesodilator .Timepoint: At Baseline, at Discharge, and after 4 weeks.—

Secondary

MeasureTime frame
To determine the safety of alternative heparin based rota-flush solution without vasodilator, as compared to rota-flush solution containing vesodilator .Timepoint: 1 month—

Countries

India

Contacts

Public ContactRajeev Krishna Chodhary

King George Medical University, Lucknow

sharadaiims@gmail.com9936001168

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026